Impact of atenolol consumption on the development of chronic renal allograft dysfunction.
Hamidian Jahromi
A R
AR
Nemazee Hospital Organ Transplantation Unit, Shiraz University of Medical Sciences, Shiraz, Iran. Hamidian@sums.ac.ir
Jahromi
A R H
AR
Raissjalali
G A
GA
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D001262:Atenolol / Q000009:adverse effects*; D001794:Blood Pressure / Q000187:drug effects; D001806:Blood Urea Nitrogen; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology*; D015994:Incidence; D016030:Kidney Transplantation / Q000473:pathology / Q000502:physiology*; D008077:Lipoproteins, LDL / Q000097:blood; D011183:Postoperative Complications / Q000453:epidemiology* / Q000503:physiopathology; D011446:Prospective Studies; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D000319:Adrenergic beta-Antagonists; D008077:Lipoproteins, LDL; D014280:Triglycerides; D001262:Atenolol